Novo Nordisk A/S vs Direxion Daily 20 Year Treasury Bull 3X Shares — how do they compare? Novo Nordisk A/S trades at $49.32 (market cap $220.53B), while Direxion Daily 20 Year Treasury Bull 3X Shares trades at $32.39. The key difference: Novo Nordisk A/S pays a 3.63% dividend while Direxion Daily 20 Year Treasury Bull 3X Shares pays none, and Novo Nordisk A/S is trading nearer its 52-week high, Direxion Daily 20 Year Treasury Bull 3X Shares nearer its low. Which is the better fit depends on your goals.
| NVO | TMF | |
|---|---|---|
Market Cap | $220.53B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $71.70 | $44.14 |
52-Week Low | $35.29 | $31.85 |
Enterprise Value | $239.49B | — |
Dividend Yield | 3.63% | — |
Trailing returns across standard periods
Latest headlines on both assets
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →TMF is a leveraged ETF that seeks to provide 300% (3x) of the daily performance of the ICE U.S. Treasury 20+ Year Bond Index. It is a tactical instrument used by sophisticated traders to capitalize on declining interest rates or to hedge against equity market volatility. Due to its daily reset mechanism and high expense ratio, TMF is structurally designed for short-term speculation rather than long-term buy-and-hold investing.
Read more on TMF →